A Comparison of the Proportions of Immune- Mediated Adverse Effects Associated with Two Different Dosing Strategies of Nivolumab

Document Type

Conference Proceeding

Publication Date

3-2018

Comments

Presented at the HOPA 14th Annual Conference in Denver, Colorado, March 2018.

This document is currently not available here.

Additional Files

Share

COinS